OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insights into a possible role of glucagon-like peptide-1 receptor agonists in the treatment of depression
Jan Detka, Katarzyna Głombik
Pharmacological Reports (2021) Vol. 73, Iss. 4, pp. 1020-1032
Open Access | Times Cited: 47

Showing 26-50 of 47 citing articles:

Metabolic disorders induced by psychotropic drugs
André Scheen
Annales d Endocrinologie (2023) Vol. 84, Iss. 3, pp. 357-363
Closed Access | Times Cited: 10

Cross‐sectional, case‐control and longitudinal associations between exposure to glucagon‐like peptide‐1 receptor agonists and the dispensing of antidepressants
Osvaldo P. Almeida, Zheng Fong, Lydia M. Hill Almeida, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 7, pp. 2925-2932
Closed Access | Times Cited: 3

Puerarin alleviates depressive-like behaviors in high-fat diet-induced diabetic mice via modulating hippocampal GLP-1R/BDNF/TrkB signaling
Yumin Liu, Ziqi Hu, Jing Wang, et al.
Nutritional Neuroscience (2022) Vol. 26, Iss. 10, pp. 997-1010
Closed Access | Times Cited: 14

Binge eating disorder, frequency of depression, and systemic inflammatory state in individuals with obesity – A cross sectional study
Nelson do Rosário Caldas, Valéria Bender Bráulio, Marco Antônio Alves Brasil, et al.
Archives of Endocrinology and Metabolism (2022)
Open Access | Times Cited: 13

Liraglutide 3.0 mg and mental health: can psychiatric symptoms be associated to adherence to therapy? Insights from a clinical audit
Silvia Tempia Valenta, Michele Stecchi, Federica Perazza, et al.
Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 6

GLP-1 agonists: superior for mind and body in antipsychotic-treated patients?
Kateřina Horská, Jana Kučerová, Silje Skrede
Trends in Endocrinology and Metabolism (2022) Vol. 33, Iss. 9, pp. 628-638
Closed Access | Times Cited: 9

Role of the Intestinal Microbiota in the Genesis of Major Depression and the Response to Antidepressant Drug Therapy: A Narrative Review
Tiziana Mundula, Simone Baldi, Elisabetta Gerace, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 550-550
Open Access | Times Cited: 4

Statins in depression: a repurposed medical treatment can provide novel insights in mental health
Riccardo De Giorgi, Philip J. Cowen, Catherine J. Harmer
International Review of Psychiatry (2022) Vol. 34, Iss. 7-8, pp. 699-714
Open Access | Times Cited: 7

Repetitive transcranial direct current stimulation modulates the brain–gut–microbiome axis in obese rodents
Agata Ziomber-Lisiak, Katarzyna Talaga-Ćwiertnia, Agnieszka Sroka-Oleksiak, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 5, pp. 871-889
Open Access | Times Cited: 6

Intestinal gluconeogenesis: A translator of nutritional information needed for glycemic and emotional balance
Amandine Gautier‐Stein, Justine Vily‐Petit, Fabienne Rajas, et al.
Biochimie (2023) Vol. 223, pp. 206-214
Open Access | Times Cited: 3

Changes in regulators of lipid metabolism in the brain: a study of animal models of depression and hypothyroidism
Katarzyna Głombik, Jan Detka, Magdalena Kukla-Bartoszek, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 5, pp. 859-870
Open Access | Times Cited: 5

Non‐insulin Parenteral Therapies
Tina Vilsbøll, Mikkel Christensen, Andreas Andersen, et al.
(2024), pp. 520-533
Closed Access

correlation between diabetes mellitus and depression
Magdalena Madera, Sylwia Mazur, Agata Mazur, et al.
Journal of Education Health and Sport (2024) Vol. 74, pp. 52086-52086
Open Access

Glucagon-like peptide-1 receptor agonists in peri-operative care
Larissa Paggers, Dieter Mesotten, Hendrik Stragier
European Journal of Anaesthesiology (2024)
Closed Access

Effects of Fzd6 on intestinal flora and neuroinflammation in lipopolysaccharide-induced depression-like mice
Wenlu Chen, Xiaoru Yan, Xiaona Song, et al.
Journal of Affective Disorders (2024) Vol. 372, pp. 160-172
Closed Access

Is the steady-state concentration, duration of action, or molecular weight of GLP-1RA associated with cardiovascular and renal outcomes in type 2 diabetes?
Shuzhen Bai, Chu Lin, Ruoyang Jiao, et al.
European Journal of Internal Medicine (2023) Vol. 109, pp. 79-88
Closed Access

Anxiety and Depression in Patients with Diabetic Retinopathy
Jonnie Ella Ortiz
Science Insights (2023) Vol. 42, Iss. 2, pp. 819-825
Open Access

Liraglutide 3.0 mg and Mental Health: Can Psychiatric Symptoms Predict Adherence to Therapy? Insights from a clinical audit
Silvia Tempia Valenta, Michele Stecchi, Federica Perazza, et al.
Research Square (Research Square) (2023)
Open Access

The Glucagon-Like Peptide-1 Analogues therapy in the non-diabetic patients
Agnieszka Sienicka, Krzysztof Kubasik, Agata Pisula
Prospects in Pharmaceutical Sciences (2023) Vol. 21, Iss. 1, pp. 9-14
Open Access

Previous Page - Page 2

Scroll to top